CORZ - Core Scientific Inc
Executive Summary
Core Scientific Inc (CORZ) operates as a technology company in the software-infrastructure sector, with operations centred on large-scale power and data-centre infrastructure designed to support high-performance compute workloads, including those associated with artificial intelligence and blockchain applications. The company is positioned as one of a small group of North American listed operators combining proprietary power capacity with hosting services for third-party compute customers.
The investment case rests on the recently confirmed AMD 2.5GW AI infrastructure supply agreement, which anchors near-term upside through incremental contracted power capacity and revenue conversion from 2026 into 2027, alongside broader power-expansion announcements that extend the platform. The primary near-term catalyst is the Q3 2026 earnings release scheduled for early November 2026, which will provide operational traction for the AMD build-out and an update on power expansion milestones. The principal risk is execution: a -703.59% reported profit margin and a -1.16B quarterly loss disclosed in the Q2 2026 10-Q and earnings release highlight that Core Scientific remains in a heavy cash-burn phase, and any delay to monetisation under the AMD contract would compress the equity case materially.
OPPORTUNISTIC BUY. Conviction Score: 59/100. The view would be upgraded on evidence of contracted revenue ramp, improving operating margins, and a credible path to profitability; it would be downgraded on further loss expansion, financing strain, or any material slippage on the AMD deployment milestones.
Thesis break: Material slippage or termination of the AMD 2.5GW supply agreement, a further deterioration in the quarterly loss beyond the -1.16B Q2 2026 disclosure, or a forced dilutive equity raise to fund expansion capex.
Business Model
Core Scientific generates revenue primarily through long-dated hosting and infrastructure agreements with third-party compute customers, including AI cloud providers and digital asset miners that lease the company's installed power capacity, cooling, and data-centre footprint. Customer concentration is meaningful, with the AMD 2.5GW supply agreement representing a step-change in contracted compute demand and shifting the revenue mix towards AI and high-performance compute workloads rather than legacy crypto-mining hosting. Smaller customer relationships continue to provide ancillary hosting and ancillary services revenue.
Margins in the current reporting period are deeply negative on a reported basis: the Q2 2026 10-Q discloses a profit margin of -703.59% alongside a quarterly loss of approximately -1.16B, reflecting heavy depreciation, expansion capex, and operating leverage that has not yet caught up with the contracted revenue base. As the AMD contract progresses from agreement to energisation and active compute, revenue should scale against a largely fixed cost base, which is the operational mechanism by which margins are expected to normalise over the 2026-2027 horizon.
The competitive moat, where it exists, sits in the company's portfolio of permitted and grid-interconnected power capacity, which is materially harder and slower to replicate than the compute hardware itself. This power-led positioning differentiates Core Scientific from pure-play GPU cloud operators that must procure power on the open market. The principal commercial risk is counterpart concentration, given that the AMD agreement represents a single dominant contracted workload; loss or delay of this relationship would materially impair the business model.
Financial Snapshot
Recent Catalysts
[29 July 2026] - Core Scientific announced the appointment of Mark Adams to the Board of Directors, disclosed via the company's investor relations press-release channel. Source: Core Scientific investor relations press release.
[27 August 2026] - Core Scientific filed a Form 8-K disclosing that it had secured $600 million of senior secured credit, providing incremental balance-sheet capacity to fund the AMD 2.5GW build-out and broader power expansion. Source: SEC Form 8-K (filed 27 August 2026, reporting event of 25 August 2026).
[August 2026] - An existing major shareholder reduced its beneficial ownership stake to 4.4% through an amended Schedule 13D/A filing, indicating partial profit-taking or portfolio rebalancing by a previously significant holder. Source: SEC Form SCHEDULE 13D/A via regulatory filing wire.
[7 August 2026] - Core Scientific released its Q2 2026 results ahead of market open, including the 10-Q and earnings release covering the quarter ended 30 June 2026, which disclosed the -703.59% profit margin and approximately -1.16B quarterly loss. Source: Core Scientific Q2 2026 10-Q and earnings release (SEC filing and company IR site).
[Early November 2026] - Q3 2026 earnings release is scheduled, which will provide an update on AMD build-out progress, power expansion milestones, and the operating leverage trajectory of the contracted revenue base. Source: Company earnings schedule on Core Scientific investor relations site.
Thesis Evaluation
Bull Case (26% weight)
The AMD 2.5GW contract advances on time, with phased energisation beginning in late 2026 and revenue contribution scaling materially through 2027; operating leverage on a largely fixed cost base drives margin expansion, and incremental non-AMD customer wins broaden the contracted workload. A sustained re-rating towards software-infrastructure comparables and a credible path to positive operating income are required. Price target $28.00 over a 12-month horizon.
Base Case (49% weight)
The AMD contract progresses broadly on schedule with modest slippage, generating partial revenue contribution in 2026 and a fuller run-rate into 2027, while reported losses narrow as the contracted revenue base scales against fixed costs. Profitability remains out of reach in the near term but the cash-burn trajectory eases, and the equity is re-rated modestly higher on contracted backlog. Price target $19.50 over a 12-month horizon.
Bear Case (25% weight)
Execution slippage on the AMD deployment, further deterioration in unit economics, or additional dilution to fund expansion capex pressures the equity; the -1.16B quarterly loss base case proves persistent rather than transitional, and counterpart or financing risk materialises. A credit-market tightening or contract delay would compound the operating loss trajectory and force a structural reset. Price target $9.50 over a 12-month horizon.
Key Risks
- Execution risk on the AMD 2.5GW contract: Phased energisation, grid upgrades, or site delivery slippage under the AMD 2.5GW supply agreement would defer revenue and extend the cash-burn window. Estimated probability: 35%. Impact: severe.
- Persistent operating losses and cash burn: The Q2 2026 10-Q disclosed a -703.59% profit margin and approximately -1.16B quarterly loss, indicating that current operating cash flow is materially negative and may require further financing. Estimated probability: 55%. Impact: severe.
- Customer concentration risk: Revenue is heavily dependent on the AMD relationship as the dominant contracted workload, leaving the income base exposed to a single counterparty. Estimated probability: 25%. Impact: severe.
- Financing and dilution risk: The $600M senior secured credit facility closed in August 2026 provides interim capacity, but ongoing capex requirements for power and data-centre expansion may necessitate additional equity or debt issuance. Estimated probability: 45%. Impact: moderate.
- Equity overhang from major shareholder sales: An existing major shareholder reduced its stake to 4.4% in August 2026 via an amended Schedule 13D/A, signalling potential further selling pressure on the share register. Estimated probability: 30%. Impact: moderate.
Who Should Own It / Avoid It
Ideal for: a growth-oriented investor with a minimum 18-24 month holding horizon, high risk tolerance, and the capacity to absorb meaningful mark-to-market volatility in a name that remains in heavy operational cash burn. The position suits investors who can underwrite negative reported earnings as a transitional phase, who understand the long lead times between contracted power agreements and revenue recognition, and who are allocating to the AI-infrastructure theme through a power-led vehicle rather than a pure-play GPU cloud operator.
Avoid if: you require positive or near-positive reported earnings, cannot tolerate equity drawdowns of 30% or more from operational or financing setbacks, or have a holding period under twelve months, as the near-term price path is likely to be driven by execution newsflow on the AMD contract and quarterly loss disclosures rather than by realised earnings. Capital-preservation mandates and income-oriented mandates should also exclude the position.
Recommendation
OPPORTUNISTIC BUY - 59/100. The tier reflects a balanced weighting between a confirmed, large-scale contracted catalyst in the AMD 2.5GW agreement and a deeply negative reported earnings base that prevents traditional valuation support. The call would upgrade on evidence of AMD energisation milestones, a narrowing quarterly loss trajectory, and incremental contracted backlog from non-AMD counterparties. It would downgrade on further loss expansion, financing strain, any material slippage to the AMD deployment, or evidence of customer concentration translating into a contract dispute. Position sizing should reflect the binary nature of contract execution and the magnitude of the reported quarterly loss relative to the current market capitalisation. At the current price of $16.45 the shares trade above our buy ceiling of $12.83: the thesis is credible but the price is not - new positions only below that level.
The probability-weighted value across our three scenarios is $19.21, 17% above the current price of $16.45 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below $12.83 - below this level the upside to the base-case target ($19.50) is at least 2x the downside to the bear case ($9.50), the minimum risk/reward we require before committing new capital.
between $12.83 and $19.50 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above $19.50 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 26%.
if material slippage or termination of the AMD 2.5GW supply agreement, a further deterioration in the quarterly loss beyond the -1.16B Q2 2026 disclosure, or a forced dilutive equity raise to fund expansion capex, regardless of price - the bear target of $9.50 is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 59/100. Trend versus prior report: Initiation.
| Report date | Conviction |
|---|---|
| 2026-10-04 | 59 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public news flow, company earnings presentations, regulatory filings, investor day materials, third-party earnings calendar coverage, and analyst commentary drawn from mainstream financial news outlets and rating-agency summaries.
Primary source types: SEC filings including Form 10-Q and Form 8-K, company press releases, investor relations materials, earnings call transcripts, regulatory announcements, and third-party research.
Key sources
- Core Scientific, Inc. (CORZ)
- Financial Results :: Core Scientific, Inc. (CORZ)
- Core Scientific, Inc. (CORZ) Stock Price, News, Quote & History - Yahoo Finance
- Press Releases :: Core Scientific, Inc. (CORZ)
- Core Scientific (CORZ) Stock Price, News & Analysis $CORZ
- July 28, 2026 - 10-Q: Quarterly report [Sections 13 or 15(d)] | Core Scientific, Inc. (CORZ)
- Core Scientific Inc (CORZ) Q2 2026 Earnings Call Highlights: Strategic Partnerships and Robust ...
- Core Scientific, AMD sign 2.5GW AI capacity deal | CORZ 8-K Filing
- The CoreWeave-Core Scientific Deal Isn't Likely to Go Through. Analysts Say That Makes CORZ Stock a Buy.
- Core Scientific Announces Second Quarter 2026 Results :: Core Scientific, Inc. (CORZ)
Data correct as of 2026-10-04